Abstract:Introduction: Cholecystokinin type-1 (CCK(1)) receptors mediate many of the physiological functions of CCK including delay of gastric emptying, pancreatic enzyme secretion, intestinal motility and gallbladder contractility. Existing in-vivo assays for the quantitative measurement of CCK(1) receptor mediated function are generally variable, limited in precision and require a relatively large number of animals to obtain statistically meaningful data. We found that they did not provide robust pharmacokinetic-pharmacodynamic data for profiling compounds acting at these receptors. Accordingly, here we describe a novel rat duodenal contractility assay that addresses these problems. Methods: Rats were anaesthetised and a saline-filled balloon was inserted through the body of the stomach and secured in the duodenum approximately 1 cm from the pyloric sphincter for measurement of intra-lumenal pressure. Studies were performed to determine a dose, rate and frequency of administration of CCK8S that produced a readily quantifiable response. Results: Initial experiments revealed that sustained exposure to CCK8S resulted in the rapid development of tachyphylaxis. After investigating different dosing paradigms, it was found that pulsatile delivery of CCK8S (intravenous infusion for 1 min every 10 min) produced a readily quantifiable contractile response that did not exhibit tachyphylaxis. The assay response output was defined as the number of contractions >5 mm Hg over baseline. The contractions were blocked in a dose-dependent manner by intravenous bolus injections of the CCK(1) receptor antagonists, dexloxiglumide (2 and 20 micromol/kg), and devazepide (3-100 nmol/kg) but not by the CCK(2) receptor antagonist gastrazole (10 micromol/kg). Conclusion: A novel, simple, high quality assay for the quantification of the in-vivo activity of CCK(1) receptor ligands is described. CCK8S delivered by pulsatile intravenous infusion to anesthetized rats produced a burst of contractile activity of the duodenum mediated by CCK(1) receptors. This activity was highly reproducible and sustained for more than 3 h providing an assay that circumvents problems associated with agonist-induced tachyphylaxis.

Effects of cholecystokinin octapeptide on contractile motility of guinea pig common bile duct

Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis

The Effect of Shudantong Granules on Animals’ Bile Secretion and Gallbladder Smooth Muscle

Cholecystokinin-8 Induces Intracellular Calcium Signaling in Cultured Myenteric Neurons from Neonatal Guinea Pigs

Effect of cholecystokinin octapeptide and glutamate on intracellur Ca2+ concentration in rat cerebo-cortical cells

ANTAGONISTIC EFFECT OF CCK-8 ON MORPHINE-INHIBITED ELECTRICAL AND CONTRACTILE ACTIVITIES OF RAT JEJUNUM IN VITRO

A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat

Effect of cyclovirobuxine D(CVB-D) on Oddi's sphincter contraction

Effects Of Cholecystokinin Receptor Blockade On Pancreatic And Biliary Function In Healthy Volunteers

CNS effects of circulating CCK8: involvement of brainstem neurones responding to gastric distension

[Effects of cholecystokinin, gastrin and proglumide on bile secretion in rats].

Identification of key residues that cause differential gallbladder response to PACAP and VIP in the guinea pig

Cholecystokinin and cholecystokinin-A receptor: An attractive treatment strategy for biliary dyskinesia?

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens

Effects of Cholecystokinin on Esophageal Motor Response to Distension in Asymptomatic Volunteers

Effects and mechanisms of growth hormone secretagogue receptor on colonic motility of mices

Purinergic activation of spontaneous transient outward currents in guinea pig taenia colonic myocytes

Effect of cholecystokinin-octapeptide on total parenteral nutrition-induced changes in hepatic bile secretion and composition in the rat.

Cholecystokinin Octapeptide Reverses the Inhibitory Effect Induced by Electroacupuncture on C-Fiber Evoked Discharges

Cholecystokinin Octapeptide Antagonized Opioid Analgesia Mediated by Μ- and Κ- but Not Δ-Receptors in the Spinal Cord of the Rat

Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor